Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Notes Payables (2016 - 2025)

SRx Health Solutions' Notes Payables history spans 13 years, with the latest figure at $3.7 million for Q2 2025.

For Q2 2025, Notes Payables changed N/A year-over-year to $3.7 million; the TTM value through Jun 2025 reached $3.7 million, changed N/A, while the annual FY2023 figure was $162000.0, N/A changed from the prior year.
Notes Payables reached $3.7 million in Q2 2025 per SRXH's latest filing, down from $3.7 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $3.7 million in Q3 2024 to a low of $162000.0 in Q4 2023.
Average Notes Payables over 3 years is $2.5 million, with a median of $3.7 million recorded in 2025.